Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-003076
Filing Date
2020-02-12
Accepted
2020-02-12 18:04:09
Documents
2
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1677
2 poa_schroeder.htm EX-24.1 12433
  Complete submission text file 0001567619-20-003076.txt   15469
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PELOTON THERAPEUTICS, INC. 2330 INWOOD ROAD, SUITE 226 DALLAS TX 75235
Business Address
Schroeder Thilo (Reporting) CIK: 0001776412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39219 | Film No.: 20605910